Komori
Yamashita Health Care Holdings (9265) · FactWorsened

Decline in Operating Cash Flow Due to Increased Working Capital

First written in FY2019-Q2. 6 of 16 entries say "Worsened", first in FY2021-Q2. Latest entry: FY2026.

16entries
8years
1from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseAdvancedFY2019 – FY2020WorsenedFY2024 – FY2026-H12019: 220192020: 220202021: 320212022: 120222023: 220232024: 220242025: 120252026: 32026
Same theme, other companies
Deterioration in Operating Cash Flow Due to Higher Working CapitalA theme 157 companies write about · 157 as a headwind · 1 as a tailwind

Yamashita Health Care Holdings moved to the "Worse" side of this theme in 2024, 2 years after the typical company in this theme (2022).

The whole theme swung hardest in 2022: 38 of 140 companies on the "Worse" side.

33 other companies' latest entry also says "Worsened".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 157 companies compared. The sentences above are computed from all 157.
Full recordFilings, disclosures and news, newest first
  1. FY2026WorsenedAnnual report

    「In the consolidated fiscal year, cash provided by operating activities was ¥88 million, compared with ¥617 million provided in the same period of the previous year. The main factors were profit before income taxes of ¥929 million, an increase of ¥431 million in inventories and a decrease of ¥315 million in trade payables.」

    The increase in operating cash flow narrowed substantially from ¥617 million in the previous year to ¥88 million. An increase in inventories and a decrease in trade payables were identified as factors behind the cash outflow.
  2. 2026-07-13MitigatedEarnings

    「During the consolidated fiscal year, cash provided by operating activities was ¥88 million.」

    Operating cash flow decreased from ¥617 million in the year-earlier period, but turned to an increase of ¥88 million for the full year after a cash decrease in the first half.
  3. FY2026-H1WorsenedAnnual report

    「In the interim consolidated accounting period, cash used in operating activities was ¥1,439 million, compared with ¥633 million used in the same period of the previous year. The main factors were a decrease of ¥528 million in trade receivables, an increase of ¥931 million in inventories and a decrease of ¥746 million in trade payables.」

    The decline in cash flow from operating activities widened from ¥633 million in the same period of the previous year to ¥1,439 million. Increases in inventories and a decrease in trade payables were identified as factors behind the cash outflow.
  4. FY2025-H1WorsenedAnnual report

    「In the interim consolidated accounting period, cash used in operating activities was ¥633 million, compared with ¥544 million used in the same period of the previous year. The main factors were an increase of ¥419 million in trade receivables, an increase of ¥687 million in inventories and an increase of ¥262 million in trade payables.」

    The decline in cash flow from operating activities widened from ¥544 million in the same period of the previous year to ¥633 million, as working-capital cash outflows due to increases in trade receivables and inventories continued.
  5. FY2024WorsenedAnnual report

    「In the consolidated fiscal year, cash provided by operating activities was ¥878 million, compared with ¥2,166 million provided in the same period of the previous year. The main factors were profit before income taxes of ¥871 million, an increase of ¥439 million in trade receivables and an increase of ¥603 million in trade payables.」

    Operating cash flow remained positive, but declined from ¥2,166 million in the same period of the previous year to ¥878 million. The increase in trade receivables and other factors resulted in a working-capital cash outflow.
  6. FY2024-Q2Narrowing decline in operating cash flowAnnual report

    「At the end of the second quarter of the current consolidated cumulative period, cash used in operating activities was ¥544 million, compared with a decrease of ¥1,865 million in the same period of the previous year. The main factors were increases of ¥667 million in trade receivables, ¥354 million in inventories and ¥532 million in trade payables.」

    The decrease in cash from operating activities narrowed from ¥1,865 million in the previous year to ¥544 million. Meanwhile, cash outflows from working capital due to increases in trade receivables and inventories continued.
  7. FY2023AdvancedAnnual report

    「During the current consolidated fiscal year, cash provided by operating activities was ¥2,166 million, compared with an increase of ¥581 million in the previous year. The main factors included profit before income taxes of ¥635 million, a decrease of ¥1,414 million in trade receivables and an increase of ¥577 million in trade payables.」

    Operating cash flow increased from ¥581 million in the previous year to ¥2,166 million, with working-capital cash inflows improving due to the decrease in trade receivables and other factors.
  8. FY2023-Q2WorsenedAnnual report

    「At the end of the second quarter of the current consolidated cumulative period, cash used in operating activities was ¥1,865 million, compared with a decrease of ¥751 million in the same period of the previous year. The main factors included increases of ¥459 million in trade receivables, ¥539 million in inventories and ¥611 million in claims in bankruptcy and reorganization proceedings, among others.」

    The decrease in cash from operating activities widened from ¥751 million in the previous year to ¥1,865 million. Increases in trade receivables, inventories and claims in bankruptcy and reorganization proceedings were identified as factors behind the cash outflow.
  9. FY2022-Q2Narrowing decline in operating cash flowAnnual report

    「At the end of the second quarter of the current consolidated cumulative period, cash used in operating activities was ¥751 million, compared with a decrease of ¥1,592 million in the same period of the previous year. The main factors included an increase of ¥1,874 million in trade receivables and an increase of ¥1,173 million in trade payables.」

    The decrease in cash from operating activities narrowed from ¥1,592 million in the previous year to ¥752 million. Meanwhile, cash outflows from working capital, including the ¥1,874 million increase in trade receivables, continued.
  10. FY2021AdvancedAnnual report

    「During the current consolidated fiscal year, cash provided by operating activities was ¥911 million, compared with an increase of ¥817 million in the previous year. The main factors included profit before income taxes of ¥1,051 million, an increase of ¥2,005 million in trade receivables and an increase of ¥2,081 million in trade payables.」

    Full-year operating cash flow increased by ¥911 million, with changes in working capital, including trade receivables of ¥2,005 million and trade payables of ¥2,081 million, reported.
  11. FY2021-Q3RestatedAnnual report

    「Current assets increased by ¥1,660 million from the end of the previous consolidated fiscal year to ¥17,731 million, mainly due to an increase in notes and accounts receivable.」

    At the end of the third quarter, an increase in notes and accounts receivable was again identified as the main factor behind the increase in current assets. No quarterly consolidated statement of cash flows was prepared.
  12. FY2021-Q2WorsenedAnnual report

    「At the end of the second quarter of the current consolidated cumulative period, cash used in operating activities was ¥1,592 million, compared with an increase of ¥613 million in the same period of the previous year. The main factors included increases of ¥2,112 million in trade receivables, ¥338 million in inventories and ¥954 million in trade payables.」

    Operating cash flow changed from an increase of ¥613 million in the previous year to a decrease of ¥1,592 million. Cash outflows from working capital increased due to increases of ¥2,112 million in trade receivables and ¥338 million in inventories, among other factors.
  13. FY2020AdvancedAnnual report

    「During the current consolidated fiscal year, cash provided by operating activities was ¥817 million, compared with a decrease of ¥101 million in the previous year. The main factors included profit before income taxes of ¥642 million and an increase of ¥295 million in trade payables.」

    Full-year operating cash flow changed from a decrease of ¥101 million in the previous year to an increase of ¥817 million.
  14. FY2020-Q2AdvancedAnnual report

    「At the end of the second quarter of the current consolidated cumulative period, cash provided by operating activities was ¥613 million, compared with a decrease of ¥1,237 million in the same period of the previous year. The main factors included profit before income taxes of ¥591 million, an increase of ¥892 million in trade receivables, an increase of ¥343 million in inventories and an increase of ¥1,509 million in trade payables.」

    Operating cash flow changed from a decrease of ¥1,237 million in the previous year to an increase of ¥613 million, with the increase in trade payables and other factors identified as the main drivers.
  15. FY2019AdvancedAnnual report

    「During the current consolidated fiscal year, cash used in operating activities was ¥101 million, compared with an increase of ¥1,493 million in the previous year. The main factors were an impairment loss of ¥210 million and a decrease of ¥396 million in trade payables.」

    Operating cash flow in the second full fiscal year decreased by ¥101 million, with the impairment loss and decrease in trade payables identified as the main factors.
  16. FY2019-Q2First statedAnnual report

    「Cash and cash equivalents at the end of the six months ended the second quarter, referred to below as “funds,” decreased by ¥1,237 million through operating activities, increased by ¥82 million through investing activities and decreased by ¥366 million through financing activities. As a result, the balance of funds decreased by ¥1,520 million from the end of the previous consolidated fiscal year to ¥1,232 million at the end of the six months ended the second quarter. The main factors were increases of ¥436 million in trade receivables and ¥228 million in inventories, together with a ¥412 million decrease in trade payables.」

    Operating cash flow decreased by ¥1,237 million, with increases in trade receivables and inventories and a decrease in trade payables identified as the main factors.
Moved together

"First-Year Third-Quarter Sales and Profit Performance" moved the same way as this thread, in the same document, in 6 of its 16 moves.

643333★123456
  1. ★This thread
  2. 1First-Year Third-Quarter Sales and Profit Performance6×
  3. 2Strengthening the Business Base through Solution-Based Sales and Healthcare Management Consulting4×
  4. 3Changes in Healthcare and Long-Term Care Delivery Systems Toward 20253×
  5. 4Group Oversight and Internal Controls through the Audit and Supervisory Committee and Internal Audits3×
  6. 5Stable and Consistent Dividends Based on a 30% Consolidated Payout Ratio3×
  7. 6Transition to a Holding Company Structure and Strengthening Group Coordination and Synergies3×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for Yamashita Health Care Holdings yet. It last moved in the Earnings of 2026-07-13: "Mitigated".
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Decline in Operating Cash Flow Due to Increased Working Capital | YAMASHITA HEALTH CARE HOLDINGS,INC. (9265) | Komori